Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-21 4:07 pm |
N/A 2034-06-19 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 4:06 pm |
N/A 2034-06-19 |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:46 pm |
N/A 2034-06-06 |
C4 Therapeutics Inc. | CCCC | Cooper Ronald Harold Wilfred Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-04-10 4:16 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Mossler Mark Chief Accounting Officer |
45,720 | $0 | 47,220 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 4:35 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,389 | $8.1 | 316,075 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 4:34 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,358 | $8.1 | 812,682 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 4:33 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
1,697 | $8.1 | 23,632 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:28 pm |
N/A 2032-01-02 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:26 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
212,950 | $0 | 212,950 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:24 pm |
N/A 2031-01-10 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
170,500 | $0 | 170,500 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:21 pm |
N/A 2032-02-13 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:19 pm |
N/A 2031-02-10 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
174,850 | $0 | 174,850 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-15 6:18 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
6,560 | $7.9 | 210,741 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:08 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
568,900 | $0 | 682,801 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:08 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer |
202,000 | $0 | 263,300 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:07 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
1,735 | $6.53 | 175,051 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:07 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
150,100 | $0 | 175,051 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
1,735 | $6.53 | 175,051 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:05 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
150,100 | $0 | 175,051 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:04 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
2,255 | $6.53 | 251,921 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:04 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
150,100 | $0 | 251,921 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:03 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,735 | $6.53 | 175,130 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:03 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
150,100 | $0 | 175,130 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:02 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
1,301 | $6.53 | 247,339 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:02 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
202,000 | $0 | 247,339 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,687 | $6.52 | 811,324 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:11 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,725 | $6.52 | 314,686 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
2,108 | $6.52 | 21,935 (Direct) |
View |
| 2023-11-16 Option Award |
2023-11-20 4:21 pm |
N/A 2033-11-15 |
C4 Therapeutics Inc. | CCCC | Hughes Owen Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-03 4:28 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
6,617 | $1.7 | 312,961 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-03 4:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
6,470 | $1.7 | 809,637 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-03 4:26 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
8,089 | $1.7 | 19,827 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:24 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
489,600 | $0 | 489,600 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:23 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:23 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:23 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:22 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:21 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
136,000 | $0 | 157,640 (Direct) |
View |
Ownership |
2023-09-19 7:20 pm |
N/A 2033-07-02 |
C4 Therapeutics Inc. | CCCC | Mossler Mark Chief Accounting Officer |
0 | $0 | 50,210 (Direct) |
View |
Ownership |
2023-09-19 7:20 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer |
0 | $0 | 215,515 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-31 4:13 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
7,500 | $0 | 168,901 (Direct) |
View |
| 2023-08-30 Tax Withholding |
2023-08-31 4:13 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
2,205 | $2.93 | 168,901 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-31 4:12 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
2,250 | $0 | 43,186 (Direct) |
View |
| 2023-08-30 Tax Withholding |
2023-08-31 4:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
661 | $2.93 | 43,186 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-31 4:11 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
2,250 | $0 | 49,186 (Direct) |
View |
| 2023-08-30 Tax Withholding |
2023-08-31 4:11 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
661 | $2.93 | 49,186 (Direct) |
View |